Will the new Medicare Part D formulary rules cause patient safety risks?

In an emailed statement by the AMA, they stated that the newly introduced guidelines to allow Medicare Part D plans to use indication-based formularies would likely reduce patient access to effective therapies and may create unanticipated patient safety risks. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.